Home  /  Resource Library  /  Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirine

Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirine

Real world study of loncastuximab tesirine for treatment of relapsed DLBCL.